AOD-9604 in Thailand: Targeted Fat Metabolism Therapy

AOD-9604 is a modified fragment of human growth hormone designed to stimulate lipolysis and inhibit lipogenesis without affecting blood sugar or insulin sensitivity. It is prescribed in physician-supervised protocols for targeted fat metabolism support and body composition improvement.

Doctor-prescribed AOD-9604 in Thailand is available at Peptides Thailand under physician supervision, with clinical-grade, COA-verified subcutaneous formulation. It is often combined with other metabolic peptides in physician-designed protocols for targeted body composition and fat management.

How AOD-9604 Works

AOD-9604 operates through sophisticated pathways to enhance fat metabolism and reduce adipose tissue. Its primary mechanism involves stimulating lipolysis (fat breakdown) and inhibiting lipogenesis (fat formation) by mimicking the fat-reducing effects of human growth hormone. The peptide also enhances the body's ability to utilize stored fat for energy, increases heat production in brown fat tissue, and may help regulate fat metabolism-related hormones. Importantly, it achieves these effects without impacting blood sugar levels or insulin sensitivity.

Medical Review Status

Last reviewed: June 2026 | Next review: December 2026

Written by Dr. Michael Ackland · Medically reviewed by Dr. Ploy Pitayanon, MD, licensed by the Medical Council of Thailand

At a Glance

Peptide

AOD-9604

Category

Injectable Peptide

Dosage

300-350mcg per injection

Frequency

Once daily

Administration

Subcutaneous injection

Potential Benefits

  • · Promotes targeted fat loss
  • · Enhances fat metabolism
  • · Supports body composition improvement

Quality Matters

Why we use Clinical-Grade only

Certificate of Analysis

Every peptide we dispense comes with a third-party COA confirming purity and potency, never grey-market sourced.

Compounded in Thailand

Manufactured in Thai FDA-licensed compounding laboratories operating under GMP standards.

Physician-prescribed only

No dispensing without a prescription. Every protocol begins with a licensed physician consultation and clinical assessment.

Medical Disclaimer

The information on this page is intended for educational and informational purposes only and should not be considered medical advice, diagnosis, or treatment. Any therapies, consultations, or prescriptions are provided only following assessment by a licensed physician and where clinically appropriate. Individual results may vary and no specific outcomes are guaranteed. Certain compounds discussed may not be approved medicines registered with the Thai FDA for specific therapeutic indications. Nothing here should be interpreted as a recommendation to self diagnose, self treat, or replace consultation with a qualified healthcare professional.

Research compound - Medical supervision required
Dr. Ploy Pitayanon, MD

Doctor's Note

Dr. Ploy Pitayanon, MD, Medical Lead

AOD-9604 requires careful medical supervision and individualized dosing. Our clinics in Chiang Mai and Phuket provide comprehensive assessment, monitoring, and ongoing support to ensure safe and effective treatment outcomes.

Potential Benefits

Promotes targeted fat loss

Enhances fat metabolism

Supports body composition improvement

May help reduce stubborn fat deposits

No effect on blood sugar levels

Supports metabolic function

May aid in cartilage repair

Helps maintain lean body mass

Supports post-exercise recovery

Demonstrates anti-inflammatory properties

Speak with a physician

Interested in AOD-9604?

All protocols require a physician assessment before any prescription is issued. Book a free video consultation with an MCT-licensed doctor.

Treatment Protocol

Dosage

300-350mcg per injection

Frequency

Once daily

Duration

8-12 weeks per cycle

Administration

Subcutaneous injection

Safety guide

AOD-9604 Side Effects & Safety

Frequency, contraindications, and who is a good candidate

Recent AOD-9604 Research

AOD-9604: Anti-Obesity Peptide Fragment of Human Growth Hormone

Reviewed AOD-9604 development as an anti-obesity drug candidate derived from the lipolytic domain of human growth hormone. Phase IIa clinical trials were underway evaluating its capacity to reduce body fat without the diabetogenic or growth-promoting side effects of full-length hGH (Curr Opin Investig Drugs, 2004).

View on PubMed

Effect of Intra-articular Injection of AOD9604 with or without Hyaluronic Acid in Rabbit Osteoarthritis Model

Demonstrated AOD9604 intra-articular injection reduced cartilage degradation and inflammatory markers in a collagenase-induced knee osteoarthritis rabbit model, with the combination of AOD9604 and hyaluronic acid showing additive chondroprotective effects (Ann Clin Lab Sci, 2015).

View on PubMed

Prefer to message first?

Chat with our team on WhatsApp. We typically reply within minutes.

Chat about AOD-9604